Skip to main navigation Skip to search Skip to main content

Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices

  • Kaike Thiê da Costa Gonçalves
  • , Vagner Deuel O. de Tavares
  • , Maria Luiza de Morais Barros
  • , Aldielyson Jorge Cavalcante de Brito
  • , Patrícia Cavalcanti-Ribeiro
  • , Fernanda Palhano-Fontes
  • , Marcelo Falchi-Carvalho
  • , Emerson Arcoverde
  • , Rafael Guimarães dos Santos
  • , Jaime E.C. Hallak
  • , Draulio Barros de Araujo
  • , Nicole Leite Galvão-Coelho
    • Universidade de São Paulo
    • Advanced Center for Psychedelic Medicine
    • Universidade Federal do Rio Grande do Norte
    • University of Calgary
    • CNPq

    Research output: Contribution to journalArticlepeer-review

    3 Citations (Scopus)

    Abstract

    This systematic review aims to elucidate the nexus between ketamine's psychoactive properties and its efficacy in treating a broad spectrum of psychiatric disorders. We searched three databases and used citation tracking to include 29 studies. Predominantly, mood disorders, including bipolar disorder (BD) and major depressive disorder (MDD) (MDD + BD: + n = 25 studies), a large part of them involve treatment-resistant patients (n = 14 studies), substance use disorder (SUD, n = 3 studies), and social anxiety disorder (SAD, n = 1 study). From all included studies (n = 29), 15 (51.72%) of them identified a positive relation between ketamine-induced altered states of consciousness and clinical outcomes, while 13 studies (44.83%) showed no linkage between them, and one study (3.45%) delineated a negative association. Focusing solely on intravenous (IV) ketamine infusions (n = 25), 14 studies (56%) reported a positive modulation of ketamine's psychoactive effects and therapeutic benefits, whereas 10 studies (40%) confirmed no relationship, and one study (4%) showed a negative association. The single study (33.34%) involving subcutaneous ketamine and all three studies (66.6%) intranasal administration did not demonstrate a significant interaction between ketamine's psychoactive effects and therapeutic response. All three SUD studies reported a positive correlation between ketamine's psychoactive effects and therapeutic response. In contrast, the single SAD study did not find a relationship between these parameters. For studies involving mood disorders (n = 25), 12 studies (48%) reported a positive relationship between psychoactive effects and therapeutic response. Others 12 studies (48%) identified a null relationship, and one study (4%) found a significant negative association. Although we have found a larger association than previous studies between ketamine's psychoactive properties and its efficacy in treating a broad spectrum of psychiatric disorders, its topic remains indeterminate, mainly due to the high heterogeneity.
    Original languageEnglish
    Pages (from-to)1271-1299
    Number of pages29
    JournalEuropean Archives of Psychiatry and Clinical Neuroscience
    Volume275
    Issue number5
    DOIs
    Publication statusPublished - Aug 2025

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Altered states of consciousness hallucinogen
    • Anxiety
    • Bipolar disorder
    • Depression
    • Dissociation
    • Esketamine
    • Ketamine
    • Mystical experiences
    • Psychedelic
    • Psychotomimetic effects
    • Substance dependence

    Fingerprint

    Dive into the research topics of 'Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices'. Together they form a unique fingerprint.

    Cite this